LYON, France & NEW YORK--(BUSINESS WIRE)--The MEDICREA group (Alternext Paris: FR0004178572 - ALMED, PEA-PME eligible), which specializes in the development and manufacturing of innovative surgical technologies for the treatment of spinal pathologies, today announced its sales for the 1st half of 2015.
Help employers find you! Check out all the jobs and post your resume.
